Credit Suisse’s MoonLake Immunotherapeutics MLTX Stock Holding History

Credit Suisse’s Portfolio MLTX Stock Details MLTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$965K	Hold
2023 Q4	$1.16M	Buy
2023 Q3	$806K	Buy
2022 Q1	–	Sell
2021 Q4	$3.68M	Buy